ATE236998T1 - Prostatakrebs-gen - Google Patents

Prostatakrebs-gen

Info

Publication number
ATE236998T1
ATE236998T1 AT00115991T AT00115991T ATE236998T1 AT E236998 T1 ATE236998 T1 AT E236998T1 AT 00115991 T AT00115991 T AT 00115991T AT 00115991 T AT00115991 T AT 00115991T AT E236998 T1 ATE236998 T1 AT E236998T1
Authority
AT
Austria
Prior art keywords
prostate cancer
biallelic markers
methods
gene
relates
Prior art date
Application number
AT00115991T
Other languages
English (en)
Inventor
Daniel Cohen
Marta Blumenfeld
Ilya Chumakou
Lydie Bougueleret
Original Assignee
Genset Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/996,306 external-priority patent/US5945522A/en
Application filed by Genset Sa filed Critical Genset Sa
Application granted granted Critical
Publication of ATE236998T1 publication Critical patent/ATE236998T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00115991T 1997-12-22 1998-12-22 Prostatakrebs-gen ATE236998T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/996,306 US5945522A (en) 1997-12-22 1997-12-22 Prostate cancer gene
US9965898P 1998-09-09 1998-09-09

Publications (1)

Publication Number Publication Date
ATE236998T1 true ATE236998T1 (de) 2003-04-15

Family

ID=26796342

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98960061T ATE197817T1 (de) 1997-12-22 1998-12-22 Prostatakrebs-gen
AT00115991T ATE236998T1 (de) 1997-12-22 1998-12-22 Prostatakrebs-gen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT98960061T ATE197817T1 (de) 1997-12-22 1998-12-22 Prostatakrebs-gen

Country Status (11)

Country Link
US (1) US6346381B1 (de)
EP (1) EP0991770B1 (de)
JP (1) JP3889927B2 (de)
AT (2) ATE197817T1 (de)
AU (1) AU750183B2 (de)
CA (1) CA2311416A1 (de)
DE (2) DE69813302T2 (de)
DK (1) DK1052292T3 (de)
ES (1) ES2190925T3 (de)
PT (1) PT1052292E (de)
WO (1) WO1999032644A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001007657A1 (en) * 1999-07-27 2001-02-01 Phylos, Inc. Peptide acceptor ligation methods
US7105353B2 (en) 1997-07-18 2006-09-12 Serono Genetics Institute S.A. Methods of identifying individuals for inclusion in drug studies
EP1068354A2 (de) * 1998-04-09 2001-01-17 Whitehead Institute For Biomedical Research Biallelische marker
EP1071817A2 (de) * 1998-04-21 2001-01-31 Genset Biallelische marker zur verwendung in der herstellung von karten des menschlichen genoms mit hoher markerdichte
US6537751B1 (en) 1998-04-21 2003-03-25 Genset S.A. Biallelic markers for use in constructing a high density disequilibrium map of the human genome
JP2002532057A (ja) * 1998-08-07 2002-10-02 ジェンセット ヒトtbc−1タンパク質をコードする核酸およびその多型マーカー
US6825004B1 (en) 1998-08-07 2004-11-30 Genset S.A. Nucleic acids encoding human TBC-1 protein and polymorphic markers thereof
US6291182B1 (en) 1998-11-10 2001-09-18 Genset Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait
WO2001014550A1 (en) * 1999-08-19 2001-03-01 Genset Prostate cancer-relased gene 3 (pg-3) and biallelic markers thereof
AU1358401A (en) * 1999-11-09 2001-06-06 Cell Therapeutics, Inc. Human lysophosphatidic acid acyltransferase-epsilon
US6562955B2 (en) * 2000-03-17 2003-05-13 Tosoh Corporation Oligonucleotides for detection of Vibrio parahaemolyticus and detection method for Vibrio parahaemolyticus using the same oligonucleotides
US20020077775A1 (en) * 2000-05-25 2002-06-20 Schork Nicholas J. Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20030195707A1 (en) * 2000-05-25 2003-10-16 Schork Nicholas J Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US7567870B1 (en) 2000-07-31 2009-07-28 Institute For Systems Biology Multiparameter analysis for predictive medicine
US7993907B2 (en) * 2001-05-08 2011-08-09 Mowycal Lending, Llc Biochips and method of screening using drug induced gene and protein expression profiling
US7343247B2 (en) * 2001-07-30 2008-03-11 The Institute For Systems Biology Methods of classifying drug responsiveness using multiparameter analysis
US20040197845A1 (en) * 2002-08-30 2004-10-07 Arjang Hassibi Methods and apparatus for pathogen detection, identification and/or quantification
TWI340168B (en) * 2003-05-07 2011-04-11 Tosoh Corp Method of detecting micrometastasis
US20050009110A1 (en) * 2003-07-08 2005-01-13 Xiao-Jia Chang Methods of producing antibodies for diagnostics and therapeutics
JP5629894B2 (ja) * 2004-12-07 2014-11-26 国立大学法人大阪大学 甲状腺乳頭癌を診断するための新規のマーカー
DE102005022047A1 (de) 2005-05-09 2006-11-30 Dade Behring Marburg Gmbh Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
NZ563913A (en) * 2005-05-18 2010-03-26 Decode Genetics Ehf Markers for prostate cancer in LD Block A on chromosome 8q24.21
NZ596070A (en) * 2009-05-08 2013-10-25 Decode Genetics Ehf Genetic variants contributing to risk of prostate cancer
US8741591B2 (en) 2009-10-09 2014-06-03 The Research Foundation For The State University Of New York pH-insensitive glucose indicator protein
US9646134B2 (en) 2010-05-25 2017-05-09 The Regents Of The University Of California Bambam: parallel comparative analysis of high-throughput sequencing data
KR101952965B1 (ko) 2010-05-25 2019-02-27 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 Bambam:고처리율 서열분석 데이터의 병렬 비교 분석
JP6298039B2 (ja) * 2012-03-27 2018-03-20 キュアバック アーゲー 人工核酸分子

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459037A (en) 1993-11-12 1995-10-17 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US5658730A (en) * 1994-12-23 1997-08-19 Ctrc Research Foundation Methods of human prostate cancer diagnosis
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
US5925519A (en) 1996-06-03 1999-07-20 The Regents Of The University Of California Genetic alterations associated with prostate cancer

Also Published As

Publication number Publication date
WO1999032644A2 (en) 1999-07-01
ATE197817T1 (de) 2000-12-15
US6346381B1 (en) 2002-02-12
EP0991770B1 (de) 2000-11-29
AU1574099A (en) 1999-07-12
PT1052292E (pt) 2003-06-30
DK1052292T3 (da) 2003-07-28
JP3889927B2 (ja) 2007-03-07
DE69813302T2 (de) 2003-12-11
CA2311416A1 (en) 1999-07-01
ES2190925T3 (es) 2003-09-01
AU750183B2 (en) 2002-07-11
DE69800415T2 (de) 2001-07-19
WO1999032644A3 (en) 1999-09-10
DE69813302D1 (de) 2003-05-15
JP2002516657A (ja) 2002-06-11
EP0991770A2 (de) 2000-04-12
DE69800415D1 (de) 2001-01-04

Similar Documents

Publication Publication Date Title
ATE197817T1 (de) Prostatakrebs-gen
White et al. Genetic association of physically unlinked islands of genomic divergence in incipient species of Anopheles gambiae
Cubells et al. Population genetics of a functional variant of the dopamine β‐hydroxylase gene (DBH)
WO1990013668A1 (en) Method for genetic analysis of a nucleic acid sample
Yin et al. Multiple single nucleotide polymorphisms on human chromosome 19q13. 2–3 associate with risk of Basal cell carcinoma
WO2000047771A3 (en) Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
WO2001000803A3 (en) Apolipoprotein a-iv-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof
Petkovski et al. SNPs and MALDI-TOF MS: tools for DNA typing in forensic paternity testing and anthropology
ATE427362T1 (de) Polymorphe marker des lsr-gens
Lee et al. Genetic characteristics and population study of 4 X-chromosomal STRs in Koreans: evidence for a null allele at DXS9898
WO1999054500A3 (en) Biallelic markers for use in constructing a high density disequilibrium map of the human genome
ATE397064T1 (de) Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon
US5773649A (en) DNA markers to detect cancer cells expressing a mutator phenotype and method of diagnosis of cancer cells
US20210180128A1 (en) Method to confirm variants in ngs panel testing by snp genotyping
Shen et al. Improved detection of global copy number variation using high density, non-polymorphic oligonucleotide probes
Bonk et al. Molecular diagnosis of familial adenomatous polyposis (FAP): genotyping of adenomatous polyposis coli (APC) alleles by MALDI-TOF mass spectrometry
ATE408025T1 (de) Biallelische marker die im zusammenhang stehen mit medikamentenmetabolismus beteiligten genen
Sánchez-García et al. Multiplex fluorescent analysis of four short tandem repeats for rapid haemophilia A molecular diagnosis
Park et al. Presymptomatic diagnosis of familial adenomatous polyposis coli
DE69833104D1 (de) Glaukom diagnose und behandlung
US20080044916A1 (en) Computational selection of probes for localizing chromosome breakpoints
Süzen et al. Molecular analysis of δ-aminolevulinic acid dehydratase (ALAD) gene polymorphism in a Turkish population
Jeffreys et al. “Major minisatellite loci” detected by minisatellite clones 33.6 and 33.15 correspond to the cognate loci D1S111 and D7S437
Ząbek et al. Epigenetic structure and the role of polymorphism in the shaping of DNA methylation patterns of equine OAS1 locus
Baldocchi et al. Design considerations for array CGH to oligonucleotide arrays

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1052292

Country of ref document: EP